John Temperato

Insider Reports History

Entity
Individual
Location
C/O Melinta Therapeutics,Inc., 300 George Street, Suite 301, New Haven, CT
Signature
/s/ Bethany Sensenig, as power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Temperato:

Stock Role Class Num Shares Value Price $ Report Date Ownership
9 METERS BIOPHARMA, INC. Chief Executive Officer, Director Common Stock 140K $31.9K $0.23 Mar 27, 2023 Direct

Insider Reports Filed by John Temperato

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NMTR 9 METERS BIOPHARMA, INC. Mar 27, 2023 1 $0 4 Mar 29, 2023 Chief Executive Officer, Director
NMTR 9 METERS BIOPHARMA, INC. Jul 6, 2022 1 $28.5K 4 Jul 8, 2022 Chief Executive Officer, Director
NMTR 9 METERS BIOPHARMA, INC. May 18, 2022 1 $22.3K 4 May 19, 2022 Chief Executive Officer, Director
NMTR 9 METERS BIOPHARMA, INC. Mar 3, 2022 1 $55.6K 4 Mar 4, 2022 Chief Executive Officer, Director
NMTR 9 METERS BIOPHARMA, INC. Feb 21, 2022 1 $0 4 Feb 23, 2022 Chief Executive Officer, Director
NMTR 9 METERS BIOPHARMA, INC. Nov 18, 2021 1 $52.5K 4 Nov 19, 2021 Chief Executive Officer, Director
NMTR 9 METERS BIOPHARMA, INC. Aug 18, 2021 1 $26.3K 4 Aug 19, 2021 Chief Executive Officer, Director